On: At $2.1M, Novartis gene therapy will be world’s most expensive drug

[aaavl2821]

At $2.1M, zolgensma will be more cost effective than spinraza, but it is not at all clear that zolgensma will be durable enough to provide 60 years of extra life

The full ICER cost effectiveness is worth a look: https://icer-review.org/wp-content/uploads/2018/07/ICER_SMA_...